Zhejiang Medicine Co Ltd (600216) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin.

Total Revenue Chart for Zhejiang Medicine Co Ltd

Zhejiang Medicine Co Ltd (600216) revenue for FY2025 was CNY 8.9B, a -5.3% change from FY2024. Zhejiang Medicine Co Ltd's revenue grew from CNY 763.6M in 1996 to CNY 8.9B in 2025 (1063.0% over 29 years). Earnings per share grew from CNY 0.03 in 2000 to CNY 1.09 in 2021 (4134.9%). Revenue compound annual growth rate: 5-year CAGR of 3.9%, 10-year CAGR of 7.0%, 20-year CAGR of 8.1%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.